Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
In a study published in Science Immunology, researchers have shown that natural killer cells (NK cells), which are a fundamental part of the body’s immune system, can recognise many different viruses including global pathogens such as Zika, dengue and Hepatitis C viruses, through a single receptor called KIR2DS2.
Lead researcher Salim Khakoo, Professor of Hepatology, said the findings are very exciting and could change the way viruses are targeted by vaccines but warned that the research is still at an early stage, and animal studies/clinical trials will be needed to test the findings.
Vaccines work by stimulating the immune response to the coat of proteins on the virus enabling the body to fight off the virus and recognise it in the future. However, the viruses are able to change their coat proteins, helping the virus to evade the antibodies, meaning some viruses can be very hard to vaccinate against.
The Southampton team have shown that this NK cell receptor is able to target a non-variable part of the virus called the NS3 helicase protein, which is essential in making the virus work properly. Unlike other proteins, the NS3 helicase protein does not change, which allows the immune system to grab hold of it and let the NK cells deal with the threat.
Professor Khakoo said: “The NS3 helicase protein could be the key in unlocking the defence of lethal viruses that affect so many people around the world. It is very exciting to discover that other viruses similar to Hepatitis C, such as Zika virus, dengue virus, yellow fever virus, Japanese encephalitis virus and in fact all flaviviruses, contain a region within their NS3 helicase proteins that is recognised by exactly the same KIR2DS2 receptor. We believe that by targeting this NS3 helicase region, we could make a new type of vaccine based upon natural killer cells, which can be used to help protect people from these infections.”
The study, which was funded by the Wellcome Trust and the Medical Research Council, analysed DNA from more than 300 patients exposed to the Hepatitis C virus, which showed that the KIR2DS2 receptor was associated with successfully clearing the virus. The team then identified that the immune system targeted the NS3 helicase protein of this using the receptor and found that it prevented the virus multiplying.
They went on to demonstrate that this same mechanism icould be important for many different viruses for example the Zika and dengue viruses, which also contain a region within their NS3 helicase protein that is recognised by the KIR2DS2 receptor.
The researchers now need to determine whether these KIR2DS2+ NK cells are protective during acute flaviviral infections, and are hoping to develop a vaccine that targets natural killer cells. They believe that a similar process could be used to target cancer.
Professor Khakoo added: “Cancer treatments that use the body’s own immune system are becoming more common. Our findings present a completely new strategy for virus therapeutics which could be easily translated into the field of cancer. The next few years are going to be very exciting in this field.”
Learn more: ‘Exciting’ discovery on path to develop new type of vaccine to treat global viruses
The Latest on: Vaccine for viruses
[google_news title=”” keyword=”vaccine for viruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- The latest on bird flu: How it's spread, what it means for milk and eggs and moreon April 27, 2024 at 8:22 am
Following continued concerns about bird flu, the Food and Drug Administration (FDA) confirmed via testing that the commercial milk supply in the United States is safe. The new tests, which were done ...
- How the US is preparing for a potential bird flu pandemicon April 26, 2024 at 2:12 pm
As the US grapples with an ongoing bird flu outbreak in dairy cattle, the country’s health agencies are ramping up surveillance efforts and working to develop a vaccine if needed ...
- Avian Flu Threat Still Low and Vaccine Measures Are Readyon April 26, 2024 at 12:56 pm
One person in the United States has been infected after exposure to a cow with avian flu, but no human-to-human transmission has occurred.
- Flu shot fatigue: influenza vaccination rates in R.I. continue to fall post-pandemicon April 25, 2024 at 2:30 am
Chalk it up to shot sickness, or maybe just an inflated sense of immunity. Either way, fewer Rhode Island adults rolled up their sleeves for a flu shot this year, though the state remains a national ...
- Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?on April 24, 2024 at 11:44 am
The first signs that H5N1 — or any new flu virus — was starting to spread from person to person would trigger a race to produce massive amounts of vaccine to try to mitigate the damage.
- Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?on April 23, 2024 at 5:00 pm
The unsettling reality of H5N1 bird flu circulating in dairy cow herds in multiple parts of the United States is raising anxiety levels about whether this dangerous virus, which has haunted the ...
- No More Endless Boosters? Scientists Develop One-for-All Virus Vaccineon April 22, 2024 at 12:32 am
End of the line for endless boosters? Researchers at UC Riverside have developed a new vaccine approach using RNA that is effective against any strain of a virus and can be used safely even by babies ...
- WHO's top scientist sounds alarm about bird flu and need for vaccine developmenton April 19, 2024 at 3:31 pm
The WHO we should be taking action to prevent bird flu. U.S. health officials say the country is ready to ramp up vaccine production.
- A one-shot vaccine for COVID, flu and future viruses? Researchers say it's comingon April 18, 2024 at 3:43 pm
But what if it were possible to protect against COVID and the flu, and other unknown viruses that haven't yet emerged, with just one shot? If that became reality, seasonal or annual boosters would be ...
- New Vaccine Could Protect Against Any Strain of a Virus With One Shoton April 18, 2024 at 6:43 am
Scientists seem to be close to creating a "one-and-done" vaccine that can protect against any strain of a virus with just one shot.
via Google News and Bing News